Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Meda Pharmaceuticals

Sky Way House, Parsonage Road, Takeley, Bishop's Stortford, CM22 6PU
Telephone: 0845 460 0000
Fax: 0845 460 0002
Medical Information Direct Line: +44 (0)1748 828 810
Medical Information e-mail: meda@professionalinformation.co.uk
Medical Information Fax: +44 (0)1748 828 801
Out of Hours contact: +44 (0)1748 828 810

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 14/04/2010
SPC Hiprex Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/04/2010 and displayed until Current
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   31-Mar-2010
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Changes to sections 7, 8 and 10 following approval of change of ownership.
Updated on 12/03/2008 and displayed until 14/04/2010
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   10/2007
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Change of MAH
Change of MA Number
Change of Date of Revision of Text
Updated on 13/09/2006 and displayed until 12/03/2008
Reasons for adding or updating:
  • Change to section 4.3 - Contra-indications
Date of revision of text on the SPC:   07/2005
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
 
4.3 Contra-indications Add Gout as conra-indication at request of MHRA
Updated on 22/08/2006 and displayed until 13/09/2006
Reasons for adding or updating:
  • Change to section 4.3 - Contra-indications
  • Pending awaiting re-submission
  • Pending awaiting re-submission
  • Pending awaiting re-submission
  • Pending awaiting re-submission
Date of revision of text on the SPC:   07/2005
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
 
4.3 Add contra-indication of gout
Updated on 18/09/2002 and displayed until 22/08/2006
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 28/08/2002 and displayed until 18/09/2002
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 07/08/2002 and displayed until 28/08/2002
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 17/07/2002 and displayed until 07/08/2002
Reasons for adding or updating:
  • Change from datasheet to SPC
Updated on 04/09/2001 and displayed until 17/07/2002
Reasons for adding or updating:
  • New SPC for new product

Active Ingredients/Generics

 
  methenamine hippurate